These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31171133)

  • 1. Interpreting the Effectiveness of Cancer Screening From National Population Statistics: Is It Sound Practice?
    Chapa J; Haslam A; Prasad V
    Mayo Clin Proc; 2019 Jun; 94(6):951-956. PubMed ID: 31171133
    [No Abstract]   [Full Text] [Related]  

  • 2. PSA screening: correlating noise with noise?
    McGregor M
    CMAJ; 2002 Aug; 167(4):340; author reply 340. PubMed ID: 12197684
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluating focus group data: barriers to screening for prostate cancer patients.
    Dale W
    Cancer Treat Res; 1998; 97():115-28. PubMed ID: 9711413
    [No Abstract]   [Full Text] [Related]  

  • 4. Controversies in PSA screening.
    O'Sullivan J
    Evid Based Med; 2017 Dec; 22(6):198. PubMed ID: 29122825
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial Comment to Active surveillance criteria for prostate cancer: can they be applied to Japanese patients?
    Suzuki M
    Int J Urol; 2012 Feb; 19(2):167-8. PubMed ID: 22092371
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer surveillance series: interpreting trends in prostate cancer--part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
    Walsh PC
    J Urol; 2000 Jan; 163(1):364-5. PubMed ID: 10604390
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer screening in the elderly.
    van Dongen JA
    Eur J Surg Oncol; 1998 Oct; 24(5):367-9. PubMed ID: 9800961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contamination by opportunistic screening in the European Randomized Study of Prostate Cancer Screening.
    Ciatto S; Zappa M; Villers A; Paez A; Otto SJ; Auvinen A
    BJU Int; 2003 Dec; 92 Suppl 2():97-100. PubMed ID: 14983964
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate specific antigen screening and active surveillance in the elderly.
    Konety BR
    J Urol; 2009 Apr; 181(4):1534-5. PubMed ID: 19230925
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to 'Receiver operating characteristics of the prostate-specific antigen test in an unselected population'.
    Izmirlian G
    J Med Screen; 2006; 13(4):214; author reply 215. PubMed ID: 17217612
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for prostate cancer: have we resolved the controversy?
    Zhu X; Roobol MJ; Schröder FH
    Curr Opin Support Palliat Care; 2010 Sep; 4(3):121-6. PubMed ID: 20489646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open letter to the American Society of Clinical Oncology.
    Green S; Crowley J; Blumenstein B; Benedetti J
    J Clin Oncol; 1998 Oct; 16(10):3478. PubMed ID: 9779727
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes?
    Carroll PR; Whitson JM; Cooperberg MR
    J Clin Oncol; 2011 Feb; 29(4):345-7. PubMed ID: 21189396
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationale for randomised trials of prostate cancer screening. The International Prostate Screening Trial Evaluation Group.
    Eur J Cancer; 1999 Feb; 35(2):262-71. PubMed ID: 10448269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Breast cancer screening lacks effectiveness].
    Merkelbach JW
    Ned Tijdschr Geneeskd; 2002 Jan; 146(3):139-40. PubMed ID: 11826675
    [No Abstract]   [Full Text] [Related]  

  • 16. Active surveillance for prostate cancer: a review.
    Klotz L
    Arch Esp Urol; 2011 Oct; 64(8):806-14. PubMed ID: 22052761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpreting the Quebec prostate cancer study.
    Labrie F; Candas B
    CMAJ; 2002 Aug; 167(4):340. PubMed ID: 12197683
    [No Abstract]   [Full Text] [Related]  

  • 18. The current and potential status of screening for prostatic cancer in asymptomatic populations.
    Murphy GP
    Prog Clin Biol Res; 1989; 303():19-25. PubMed ID: 2674985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The National Board of Health and Welfare's guidelines for prostatic cancer care. PSA test screening--only for well-informed men].
    Bratt O; Damber JE; Kärvinge C; Malm T; Hensjö LO; Hyttsten E
    Lakartidningen; 2008 Feb 20-26; 105(8):524-8. PubMed ID: 18363292
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness of prostate cancer screening and treatment.
    Hahn DL
    Ann Intern Med; 1993 Nov; 119(10):1054; author reply 1055. PubMed ID: 8214991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.